TRANSITN THERAP (TTHI)
(Real Time Quote from BATS)
$1.52 USD
0.00 (0.32%)
Updated Aug 30, 2016 03:58 PM ET
After-Market: $1.52 (%) 1:52 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[TTHI]
Reports for Purchase
Showing records 1 - 11 ( 11 total )
Industry: Medical - Biomedical and Genetics
Neuropsychiatric Symptoms in Alzheimer?s Disease: Clinical Trial Challenges
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Biomedical and Genetics
Bringing Some HARMONY to Agitation and Aggression
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: FEIN A
Industry: Medical - Biomedical and Genetics
On Track for 2 Value-Driving Data Readouts in 2015: Alzheimer?s and Diabetes
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: FEIN A
Industry: Medical - Biomedical and Genetics
Potential Catalysts Draw Near: Down Syndrome Data this Week; Alzheimer''s Data in 2Q15
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: FEIN A
Industry: Medical - Biomedical and Genetics
We are suspending coverage in order to focus on other areas of interest to our institutional clients
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Making progress in clinical trials and looking at potential candidates
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Industry: Medical - Biomedical and Genetics
We are transferring coverage as a result of reorganization of our coverage universe
Provider: STONEGATE CAPITAL MARKETS
Industry: Medical - Biomedical and Genetics
Initiation of Coverage: TTHI: Eli Lilly partnership for diabetes leads to milestone as Company explores compounds for other diseases.
Provider: STONEGATE CAPITAL MARKETS
Analyst: RODRIGUEZ M
Industry: Medical - Biomedical and Genetics
ValuEngine Detailed Valuation Report for TTHI
Provider: VALUENGINE, INC
|